Loading insider details...
Beta
Latest Form 4 (Jun 23, 2026): Exercise/Conversion of 2,816 AGIO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 23, 2026 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Exercise/Conversion | 2,816 | n/a |
| Jun 8, 2026 | Prime Medicine, Inc. (PRME) | Grant/Award | 75,000 | n/a |
| Aug 6, 2025 | Prime Medicine, Inc. (PRME) | Disposition to Issuer | 13,510 | n/a |
| Jun 23, 2025 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Exercise/Conversion | 2,120 | n/a |
| Jun 5, 2025 | Prime Medicine, Inc. (PRME) | Grant/Award | 55,000 | n/a |
| Jun 24, 2024 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Grant/Award | 2,120 | n/a |
| Jun 17, 2024 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Exercise/Conversion | 3,388 | n/a |
| Jun 14, 2024 | Prime Medicine, Inc. (PRME) | Grant/Award | 45,000 | n/a |
| Mar 11, 2024 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Sale | 1,285 | $40.6K |
| Mar 7, 2024 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Sale | 300 | $9.7K |